Rheumatology Journals

Rheumatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Polyzos SA et al. – This review summarizes available data on the pathogenesis, epidemiology, clinical manifestation, biochemical assessment and management of PDB, giving special attention to the treatment of PDB with zoledronic acid, based on current evidence.

Related Articles

Paget's disease of bone
Expert Review of Endocrinology & Metabolism, 11/10/09    Relevance Score: 66%

Recent advances in understanding the molecular basis of Paget's disease of bone
Journal of Clinical Pathology, 11/10/09    Relevance Score: 66%

Significance of nipple enhancement of Pagets disease in contrast enhanced breast MRI
Archives of Gynecology and Obstetrics, 10/20/09    Relevance Score: 66%

Serum homocysteine, folate and vitamin B12 in patients with Paget's disease of bone: the effect of zoledronic acid
Journal of Bone and Mineral Metabolism, 11/09/09    Relevance Score: 64%

Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history
Expert Review of Gastroenterology & Hepatology, 10/13/09    Relevance Score: 47%

Today in Bone Metabolism...keeping you current

Use of bisphosphonates in the treatment of pediatric osteoporosis
International Journal of Clinical Rheumatology, 12/04/09

Vitamin K2 supplementation does not influence bone loss in early menopausal women: A randomised double-blind placebo-controlled trial
Osteoporosis International, 12/03/09

A perspective on male osteoporosis
Best Practice & Research: Clinical Rheumatology, 12/03/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address